Fibroblast Activation Protein (FAP) Overexpression Induces Epithelial–Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma by Down-Regulating Dipeptidyl Peptidase 9 (DPP9)

Fibroblast Activation Protein (FAP) Overexpression Induces Epithelial–Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma by Down-Regulating Dipeptidyl Peptidase 9 (DPP9)

Qing-qing Wu,1 Meng Zhao,1 Guang-zhao Huang,1 Ze-nan Zheng,1 Yuechuan Chen,1 Wei-sen Zeng,2 Xiao-zhi Lv1 1Department of Oral & Maxillofacial Surgery, NanFang Hospital, Southern Medical University, Guangzhou, People’s Republic of China; 2Department of Cell Biology, School of Basic M...

Full description

Bibliographic Details
Main Authors:	Wu Q, Zhao M, Huang G, Zheng Z, Chen Y, Zeng W, Lv X
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-03-01
Series:	OncoTargets and Therapy
Subjects:	fap dpp9 emt oscc oral cancer
Online Access:	https://www.dovepress.com/fibroblast-activation-protein-fap-overexpression-induces-epithelialnda-peer-reviewed-article-OTT

Similar Items

Heterogeneity of molecular forms of dipeptidyl peptidase-IV and fibroblast activation protein in human glioblastomas
by: Ivana Matrasova, et al.
Published: (2017-09-01)

The Role of Carcinogenesis-Related Biomarkers in the Wnt Pathway and Their Effects on Epithelial–Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma
by: Yunpeng Bai, et al.
Published: (2020-02-01)

Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines
by: Hyeong Sim Choi, et al.
Published: (2019-06-01)

FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2
by: Yang Chen, et al.
Published: (2021-08-01)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
by: Jinglong Liu, et al.
Published: (2014-04-01)

Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach
by: Tak-Kee Choy, et al.
Published: (2021-07-01)

In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA<sup>5</sup>.SA.FAPi and DOTA.SA.FAPi
by: Euy Sung Moon, et al.
Published: (2021-06-01)

Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells
by: Shaolan Li, et al.
Published: (2020-01-01)

Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach
by: Isabelle M.E. Lacroix, et al.
Published: (2012-04-01)

DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
by: Erna Kristin
Published: (2016-12-01)

Reduced humidity induces skin barrier dysfunction and secretion of dipeptidyl peptidase-4 (DPP-4) in a skin-equivalent model
by: Lee Sung Hoon, et al.
Published: (2019-01-01)

Biochemical Characterization of Dipeptidyl Peptidase IV (DPP-IV) and DPP9
by: Hung-Kuan Tang, et al.
Published: (2009)

Elevated Dipeptidyl Peptidase IV (DPP-IV) Activity in Plasma from Patients with Various Lysosomal Diseases
by: Agnieszka Ługowska, et al.
Published: (2021-02-01)

Selective Activity-Based Probes Targeting Fibroblast Activation Protein (FAP)
by: Johannes Vrijdag, et al.
Published: (2019-08-01)

Combination treatment for type 2 diabetes mellitus (T2DM) : dipeptidyl peptidase-4 inhibitors (DPP-4) and metformin
by: Erna Kristin
Published: (2017-10-01)

The effect of tranilast on fibroblast activation protein α (FAP-α) expression in normal and keloid fibroblasts in vitro
by: Paweł P. Antończak, et al.
Published: (2017-07-01)

Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study
by: Alice Blet, et al.
Published: (2021-02-01)

A novel Notch1 missense mutation (C1133Y) in the Abruptex domain exhibits enhanced proliferation and invasion in oral squamous cell carcinoma
by: Yang Zheng, et al.
Published: (2018-01-01)

Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients
by: Jit Sarkar, et al.
Published: (2019-07-01)

“The Penuries of the Precursors”. A study of FAP (Fuerzas Armadas Peronistas) experience
by: Horacio Divito
Published: (2018-06-01)

Recurrent <it>APC </it>gene mutations in Polish FAP families
by: Pławski Andrzej, et al.
Published: (2007-12-01)

Mapping Salivary Proteases in Sjögren’s Syndrome Patients Reveals Overexpression of Dipeptidyl Peptidase-4/CD26
by: Laís Garreto, et al.
Published: (2021-06-01)

UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4
by: T. V. Romanova, et al.
Published: (2018-06-01)

Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression
by: Ming-xin Cao, et al.
Published: (2020-06-01)

Involvement of DPP9 in gene fusions in serous ovarian carcinoma
by: Marianne Lislerud Smebye, et al.
Published: (2017-09-01)

Altered Tissue and Plasma Levels of Fibroblast Activation Protein-α (FAP) in Renal Tumours
by: Jon Danel Solano-Iturri, et al.
Published: (2020-11-01)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
by: Kaisa Tasanen, et al.
Published: (2019-06-01)

STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma via Inhibiting FoxO1
by: Min Zheng, et al.
Published: (2019-11-01)

Investigation of <i>Chlorella pyrenoidosa</i> Protein as a Source of Novel Angiotensin I-Converting Enzyme (ACE) and Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides
by: Yuchen Li, et al.
Published: (2021-05-01)

Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
by: Paul Windisch, et al.
Published: (2021-02-01)

DPP9: Comprehensive In Silico Analyses of Loss of Function Gene Variants and Associated Gene Expression Signatures in Human Hepatocellular Carcinoma
by: Jiali Carrie Huang, et al.
Published: (2021-04-01)

Long Noncoding RNA ZEB1-AS1 Downregulates miR-23a, Promotes Tumor Progression, and Predicts the Survival of Oral Squamous Cell Carcinoma Patients
by: Wang X, et al.
Published: (2021-04-01)

Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs
by: Swayam Prakash Srivastava, et al.
Published: (2020-02-01)

DPP4 in Diabetes
by: Diana eRöhrborn, et al.
Published: (2015-07-01)

Dipeptidyl peptidase IV: An attractive target for the development of effective diagnostic and therapeutic strategies
by: Agata Jackiewicz, et al.
Published: (2018-05-01)

The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure
by: Masanori Hirose, et al.
Published: (2017-12-01)

Association between Dipeptidyl Peptidase-4 Inhibitors and Allergic Rhinitis in Asian Patients with Diabetes
by: Hsin-Hung Chen, et al.
Published: (2019-04-01)

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
by: Ming Li, et al.
Published: (2020-12-01)

FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
by: Li-Na Yu, et al.
Published: (2019-12-01)

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators
by: Euy Sung Moon, et al.
Published: (2020-07-01)